284 related articles for article (PubMed ID: 17520317)
1. Heme oxygenase-1 gene promoter polymorphism is associated with risk of gastric adenocarcinoma and lymphovascular tumor invasion.
Lo SS; Lin SC; Wu CW; Chen JH; Yeh WI; Chung MY; Lui WY
Ann Surg Oncol; 2007 Aug; 14(8):2250-6. PubMed ID: 17520317
[TBL] [Abstract][Full Text] [Related]
2. Association of susceptibility to the development of lung adenocarcinoma with the heme oxygenase-1 gene promoter polymorphism.
Kikuchi A; Yamaya M; Suzuki S; Yasuda H; Kubo H; Nakayama K; Handa M; Sasaki T; Shibahara S; Sekizawa K; Sasaki H
Hum Genet; 2005 Apr; 116(5):354-60. PubMed ID: 15688187
[TBL] [Abstract][Full Text] [Related]
3. Association between GT-repeat polymorphism at heme oxygenase-1 gene promoter and gastric cancer and metastasis.
Motovali-Bashi M; Hamidy M
Tumour Biol; 2015 Jun; 36(6):4757-62. PubMed ID: 25956277
[TBL] [Abstract][Full Text] [Related]
4. [The risk of esophageal squamous cell carcinoma associated with microsatellite polymorphism in promoter of heme oxygenase-1].
Hu B; Zhang J; Wang J; Zhu C; Chen B; Kong M; Zhang B; Zhu M
Zhonghua Wai Ke Za Zhi; 2015 Mar; 53(3):206-10. PubMed ID: 26269017
[TBL] [Abstract][Full Text] [Related]
5. The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors.
Funk M; Endler G; Schillinger M; Mustafa S; Hsieh K; Exner M; Lalouschek W; Mannhalter C; Wagner O
Thromb Res; 2004; 113(3-4):217-23. PubMed ID: 15140586
[TBL] [Abstract][Full Text] [Related]
6. Association of the microsatellite (GT)n repeat polymorphisms of the HO-1 gene promoter and corresponding serum levels with the risk of laryngeal squamous cell carcinoma.
Tang D; Tang WJ; Shi XL; Li WP; Zhou H; Lu LM; Tao L
Acta Otolaryngol; 2016 Aug; 136(8):806-11. PubMed ID: 27400252
[TBL] [Abstract][Full Text] [Related]
7. Effect of oral N-acetylcysteine on COPD patients with microsatellite polymorphism in the heme oxygenase-1 gene promoter.
Zhang JQ; Zhang JQ; Fang LZ; Liu L; Fu WP; Dai LM
Drug Des Devel Ther; 2015; 9():6379-87. PubMed ID: 26674585
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers.
Chang KW; Lee TC; Yeh WI; Chung MY; Liu CJ; Chi LY; Lin SC
Br J Cancer; 2004 Oct; 91(8):1551-5. PubMed ID: 15365571
[TBL] [Abstract][Full Text] [Related]
9. A microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with risk for melanoma.
Okamoto I; Krögler J; Endler G; Kaufmann S; Mustafa S; Exner M; Mannhalter C; Wagner O; Pehamberger H
Int J Cancer; 2006 Sep; 119(6):1312-5. PubMed ID: 16596642
[TBL] [Abstract][Full Text] [Related]
10. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.
Chen YH; Lin SJ; Lin MW; Tsai HL; Kuo SS; Chen JW; Charng MJ; Wu TC; Chen LC; Ding YA; Pan WH; Jou YS; Chau LY
Hum Genet; 2002 Jul; 111(1):1-8. PubMed ID: 12136229
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
[TBL] [Abstract][Full Text] [Related]
12. Association of heme oxygenase-1 GT-repeat polymorphism with blood pressure phenotypes and its relevance to future cardiovascular mortality risk: an observation based on arsenic-exposed individuals.
Wu MM; Chiou HY; Chen CL; Hsu LI; Lien LM; Wang CH; Hsieh YC; Wang YH; Hsueh YM; Lee TC; Cheng WF; Chen CJ
Atherosclerosis; 2011 Dec; 219(2):704-8. PubMed ID: 21945498
[TBL] [Abstract][Full Text] [Related]
13. HO-1 promoter polymorphism associated with rheumatoid arthritis.
Rueda B; Oliver J; Robledo G; López-Nevot MA; Balsa A; Pascual-Salcedo D; González-Gay MA; González-Escribano MF; Martín J
Arthritis Rheum; 2007 Dec; 56(12):3953-8. PubMed ID: 18050210
[TBL] [Abstract][Full Text] [Related]
14. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.
Yamada N; Yamaya M; Okinaga S; Nakayama K; Sekizawa K; Shibahara S; Sasaki H
Am J Hum Genet; 2000 Jan; 66(1):187-95. PubMed ID: 10631150
[TBL] [Abstract][Full Text] [Related]
15. Effect of heme oxygenase-1 gene promoter polymorphism on cancer risk by histological subtype: A prospective study in arseniasis-endemic areas in Taiwan.
Wu MM; Lee CH; Hsu LI; Cheng WF; Lee TC; Wang YH; Chiou HY; Chen CJ
Int J Cancer; 2016 Apr; 138(8):1875-86. PubMed ID: 26566708
[TBL] [Abstract][Full Text] [Related]
16. GT-repeat polymorphism in the heme oxygenase-1 gene promoter is associated with cardiovascular mortality risk in an arsenic-exposed population in northeastern Taiwan.
Wu MM; Chiou HY; Chen CL; Wang YH; Hsieh YC; Lien LM; Lee TC; Chen CJ
Toxicol Appl Pharmacol; 2010 Nov; 248(3):226-33. PubMed ID: 20708634
[TBL] [Abstract][Full Text] [Related]
17. Association between heme oxygenase-1 gene promoter polymorphisms and type 2 diabetes in a Chinese population.
Song F; Li X; Zhang M; Yao P; Yang N; Sun X; Hu FB; Liu L
Am J Epidemiol; 2009 Sep; 170(6):747-56. PubMed ID: 19696228
[TBL] [Abstract][Full Text] [Related]
18. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
[TBL] [Abstract][Full Text] [Related]
19. Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients.
Lin CC; Yang WC; Lin SJ; Chen TW; Lee WS; Chang CF; Lee PC; Lee SD; Su TS; Fann CS; Chung MY
Kidney Int; 2006 Jan; 69(1):165-72. PubMed ID: 16374439
[TBL] [Abstract][Full Text] [Related]
20. Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.
Murakami A; Fujimori Y; Yoshikawa Y; Yamada S; Tamura K; Hirayama N; Terada T; Kuribayashi K; Tabata C; Fukuoka K; Tamaoki T; Nakano T
Lung; 2012 Jun; 190(3):333-7. PubMed ID: 22271370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
